The Associated Press has published a startling investigative report based on a DEA whistleblower’s account: agents in Albuquerque monitored massive shipments of fentanyl pills and, according to Special Agent David Howell, allowed them to be delivered so prosecutors could build bigger cases. Howell’s claim — “We poisoned our community to make cases” — is a blunt charge. If true, it says our federal law-enforcement strategy put courtroom trophies ahead of human lives.
What the AP investigation revealed about DEA, fentanyl pills, and New Mexico
The AP story rests on interviews, whistleblower filings and internal records. Howell says DEA teams tracked deliveries that added up to at least 1.8 million fentanyl pills moving into New Mexico during a multi‑state probe. Agents recorded specific drops — one transaction logged roughly 74,000 pills — yet did not interdict them. Advocacy group Empower Oversight has pushed for congressional and inspector‑general probes, and the whistleblower’s attorney warns the policy of letting drugs flow into communities mirrors past government blunders.
Official denials, watchdog findings, and the policy backdrop
The DEA says its decisions were “lawful, reasonable under the circumstances and consistent with Department guidance,” and the U.S. attorney’s office in Albuquerque claims current leadership is focused on aggressively prosecuting fentanyl traffickers. But this fight over tactics did not spring up overnight. Justice Department “Fentanyl Protocols” from 2017 emphasized seizing drugs when practicable; a 2024 rewrite gave more discretion to weigh public‑safety risks against investigative benefits. Watchdog reviews have been mixed: the Justice Department’s internal Office of Professional Responsibility once cleared the tactics as reasonable, while the Office of Special Counsel earlier flagged a “substantial likelihood of wrongdoing.” Meanwhile, the DEA publicized a record seizure in 2025 — more than 3 million pills seized in a takedown — showing both the scale of the problem and the confusion over tactics.
Lives vs. “bigger fish”: the human cost of a prosecutorial gamble
Howell links the tactic to overdose deaths in New Mexico, where fatalities rose sharply while national rates fell. The AP noted tragic examples, including a toddler’s death tied to fentanyl residue. Prosecutors like Alex Uballez have defended letting some shipments go to catch bigger dealers — “the bigger fish are worth catching,” the logic goes. That reads like a cold cost‑benefit memo: sacrifice neighborhoods now, prosecute the big players later. Call it criminal justice as chess, while families grieve in the streets.
This AP revelation deserves more than a press statement from the DEA and an internal review memo. Congress and the inspector general should open a clear, public probe that connects specific decisions to their consequences. If agents did, in fact, allow millions of lethal pills to reach local markets, those choices need to be answered for — not smoothed over with bureaucratic weasel words. Law enforcement should be about protecting people, not optimizing case totals. If we’ve reached the point where federal strategy risks becoming a death sentence for communities, voters and lawmakers must demand accountability and a return to common‑sense policies that put lives first.

